Pharmacokinetic evaluation of conventional and controlled-release product of naproxen

The bioavailability and pharmacokinetics of a new controlled-release tablet of naproxen (750 mg tablet) have been determined, relative to an equivalent dose of conventional product, by a cross-over study in twenty healthy volunteers